An interventional study of Epigenetics Video and Nanotechnology Video in Healthy, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 585 studies in Behavior with a site in United States — 87 open to participants now, 118 under way, 2 of them phase 3. Behavior · United States.
Among the 585 studies in Behavior with a site in United States, this one is the 39th largest by enrollment of the 495 interventional ones that give a count, is one of 34 that started in 2025, is one of 431 with no phase, and was the 545th registered.
1,579 studies on the registry are indexed under Behavior; 314 are open to participants now.
Browse Behavior studies →87 of the 585 studies in Behavior with a site in United States are open now. Recruiting first, the newest first:
Columbia University · Sites in United States
Ages 12–80
Healthy Tarrant County Collaboration · Sites in United States
Ages 18+
KDH Research & Communication · Sites in United States
Ages 18+ · Men only · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 18–24
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 177 Behavior studies recruiting now, 77 (44%) set no upper age limit and 72 (41%) stop at 75 or younger; 58 take children under 18; 99 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
585 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 33 · Phase 3 14 · Phase 4 11
First in 1989; this study’s year is marked. 34 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 2,040 is above the median of 120 across 1,202 interventional studies indexed under Behavior.
Median enrollment 121 across the 495 interventional studies, 122 across the 89 observational. Of the 432 that completed or were terminated, 110 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 585 have an industry lead sponsor. The 10 most frequent:
Washington University School of Medicine is the lead sponsor of 1,806 studies on the registry; 271 are open to participants now.
Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.
Washington University School of Medicine has 9 studies filed under Behavior — fewer than ten, so there is no comparison to draw.
49 of the studies in Behavior with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07217145Phase 3University of UtahPREVENT HPV -Related Cancers Trial | 2026-11 |
| NCT06099197Indiana UniversityI-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals | 2026-11 |
| NCT04481061Children's Hospital Medical Center, CincinnatiEngaging Adolescents in Decisions About Return of Genomic Research Results | 2026-11-30 |
| NCT05677360H. Lee Moffitt Cancer Center and Research InstituteHPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) | 2026-12 |
| NCT03938610Pamela HughesDo Script Concordance Tests Correlate With Family Medicine Standardized Tests and Failing Rotation Grades? | 2026-12 |
Add all 49 to your calendar (.ics) → With an account.
Among the 585 studies in Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about epigenetics that are understandable and that increase acceptance of using epigenetics in clinical settings.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
English language speaker,
Identify as one of five racial/ethnic groups:
Exclusion Criteria:
Participants will watch a brief (\<5 minute) video about the concept of Epigenetics
Behavioral: Epigenetics Video
Participants will watch a brief (\<5 minute) video about nanotechnology
Behavioral: Nanotechnology Video
Educational video about health and epigenetics.
Educational video about nanotechnology
Knowledge & Understanding of Epigenetics Information
We will measure this outcome using a sum score of correct answers for 8 individual items. Scale ranges from 0 points to 8 points with higher scores indicating higher epigenetics knowledge.
Time frame: After intervention video
Acceptability of Epigenetics Information
We will measure this outcome using 3 different constructs including perceived benefits of epigenetic research (items 1-7, ranging from 1 to 5 with higher scores indicating higher perceived benefits), perceived drawbacks of epigenetic research (items 8-10, ranging from 1 to 5 with higher scores indicating higher perceived drawbacks), and acceptance of using epigenetic research in medical support (items 11-13, ranging from 1 to 5 with higher scores indicating higher acceptance of using epigenetic research in medical support). Each item was analyzed separately.
Time frame: After intervention video
Perceptions of Epigenetic Information
We will measure this outcome using an 6 item scale. Scores range from 1 to 5, with higher scores indicating greater perceptions of epigenetic information.
Time frame: After intervention video
| Milestone | Epigenetics Video | Nanotechnology Video |
|---|---|---|
| Started | 1637 | 403 |
| Completed | 1637 | 403 |
| Not completed | 0 | 0 |
We will measure this outcome using a sum score of correct answers for 8 individual items. Scale ranges from 0 points to 8 points with higher scores indicating higher epigenetics knowledge.
| Sum Score of Knowledge Items | Epigenetics Video | Nanotechnology Video |
|---|---|---|
| Knowledge & Understanding of Epigenetics Information | 5.44 ± 0.13 | 4.09 ± 0.28 |
We will measure this outcome using 3 different constructs including perceived benefits of epigenetic research (items 1-7, ranging from 1 to 5 with higher scores indicating higher perceived benefits), perceived drawbacks of epigenetic research (items 8-10, ranging from 1 to 5 with higher scores indicating higher perceived drawbacks), and acceptance of using epigenetic research in medical support (items 11-13, ranging from 1 to 5 with higher scores indicating higher acceptance of using epigenetic research in medical support). Each item was analyzed separately.
| Points on a survey item | Epigenetics Video |
|---|---|
| 1. How beneficial do you think epigenetics research will be for society as a whole? | 3.8 ± 1 |
| 2. How beneficial do you think epigenetics research will be for you personally? | 3.1 ± 1.2 |
| 3. How beneficial do you think epigenetics research will be for improving medical treatments? | 3.8 ± 1 |
| 4. How confident are you that epigenetics research will help fix human health problems and diseases? | 3 ± 1.1 |
| 5. ...Epigenetics research will remove stigma around human health problems and diseases? | 2.6 ± 1.1 |
| 6. How confident are you that epigenetics research will produce medical advances? | 3.3 ± 1.1 |
| 7...Medical advances from epigenetics research will be affordable for most people? | 1.9 ± 1 |
| 8...Epigenetics research will increase stigma around human health problems and diseases? | 2.2 ± 1 |
| 9...will lead to discrimination against those who have potentially harmful epigenetic tags? | 2.4 ± 1.1 |
| 10...will lead to politicians passing laws that tell pregnant people what they can and can't do? | 2.6 ± 1.3 |
| 11. Epigenetics research findings should be used to treat human medical conditions. | 3.8 ± 1.1 |
| 12. Epigenetics research findings should be used to restore health. | 3.8 ± 1.1 |
| 13. Epigenetics research findings should be used to enhance or improve human abilities. | 3.2 ± 1.4 |
We will measure this outcome using an 6 item scale. Scores range from 1 to 5, with higher scores indicating greater perceptions of epigenetic information.
| Points on an averaged scale | Epigenetics Video | Nanotechnology Video |
|---|---|---|
| Perceptions of Epigenetic Information | 3.79 (3.74 to 3.84) | 3.42 (3.32 to 3.53) |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Epigenetics Video | — | — | — |
| Nanotechnology Video | — | — | — |
| Age, Continuous(Years) | Epigenetics Video | Nanotechnology Video | Total |
|---|---|---|---|
| Mean | 48 ± 17 | 50 ± 17 | 48 ± 17 |
| Sex: Female, Male(Participants) | Epigenetics Video | Nanotechnology Video | Total |
|---|---|---|---|
| Female | 903 | 207 | 1110 |
| Male | 734 | 196 | 930 |
| Race (NIH/OMB)(Participants) | Epigenetics Video | Nanotechnology Video | Total |
|---|---|---|---|
| American Indian or Alaska Native | 81 | 30 | 111 |
| Asian | 296 | 76 | 372 |
| Native Hawaiian or Other Pacific Islander | 9 | 6 | 15 |
| Black or African American | 306 | 89 | 395 |
| White | 544 | 130 | 674 |
| More than one race | 192 | 72 | 264 |
| Unknown or Not Reported | 209 | 0 | 209 |
| Ethnicity (NIH/OMB)(Participants) | Epigenetics Video | Nanotechnology Video | Total |
|---|---|---|---|
| Hispanic or Latino | 321 | 87 | 408 |
| Not Hispanic or Latino | 1316 | 316 | 1632 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(Participants) | Epigenetics Video | Nanotechnology Video | Total |
|---|---|---|---|
| United States | 1637 | 403 | 2040 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes
Ran from Jun 2025 to primary completion in Jul 2025, 1 month.
Results were first posted in Oct 2026, 1 year 2 months after primary completion.
Of 745 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's 1 month is below that.
Counting every sponsor, half of 761 studies reached it within 13 months; a quarter within 5 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington University School of Medicine →